MOMO'S BREAKOUT BOARD

[dirkv]

Quince Therapeutics, Inc. (QNCX) : 1.0000-0.0800 (-7.41%)


Jan 30 (Reuters) - Quince Therapeutics Inc :
* QUINCE THERAPEUTICS - ON JANUARY 24, BOARD OF COMPANY
APPROVED
COST REDUCTION PROGRAM TO ALIGN OPERATIONS WITH CHANGES IN
CORPORATE STRATEGY
* QUINCE THERAPEUTICS - UNDER PLAN, COMPANY IS REDUCING
HEADCOUNT
BY APPROXIMATELY 47% THROUGH A REDUCTION IN ITS WORKFORCE
* QUINCE THERAPEUTICS - REDUCTION IN FORCE WILL BEGIN IN
FEBRUARY
2023 AND WILL BE COMPLETED BY APRIL 2023
* QUINCE THERAPEUTICS - AS A RESULT, EXPECTS TO REALIZE
ESTIMATED
ANNUALIZED OPERATING EXPENSE SAVINGS OF ABOUT $9.5 MILLION IN
YEAR ENDING DEC 31, 2023
* QUINCE THERAPEUTICS - REDUCTION IN FORCE WILL BEGIN IN
FEBRUARY
2023 AND WILL BE COMPLETED BY APRIL 2023
* QUINCE THERAPEUTICS - EXPECTS TO REALIZE ESTIMATED
ANNUALIZED
OPERATING EXPENSE SAVINGS OF APPROXIMATELY $9.5 MILLION IN YEAR
ENDING DECEMBER 31, 2023
* QUINCE THERAPEUTICS - IN CONNECTION WITH PLAN, COMPANY
ESTIMATES
THAT IT WILL INCUR EXPENSES OF APPROXIMATELY $0.6 MILLION TO
$0.8 MILLION


Jan 01, 2023 0.6450 1.4700 0.6370 1.0800 1.0800 67,051,000
Dec 01, 2022 0.7490 0.7600 0.5400 0.6370 0.6370 5,975,600
Oct 31, 2022 1.0000 1.0390 0.6500 0.7370 0.7370 5,404,500
Sep 30, 2022 1.3700 1.3700 0.8620 1.0000 1.0000 3,903,500
Aug 31, 2022 1.7300 1.7580 1.2000 1.3300 1.3300 4,722,200
Jul 31, 2022 1.9700 2.7170 1.6500 1.7600 1.7600 5,607,500
Jun 30, 2022 2.2700 2.5800 1.7820 1.9500 1.9500 6,220,200
May 31, 2022 2.6300 3.3500 2.1240 2.2200 2.2200 13,239,100
Apr 30, 2022 3.6800 4.0360 2.5500 2.5900 2.5900 9,053,400
Mar 31, 2022 6.1900 6.8000 3.5000 3.6600 3.6600 8,466,600
Mar 01, 2022 4.3900 6.6300 4.1600 6.1900 6.1900 11,176,500
Feb 01, 2022 6.1000 7.2800 3.7920 4.3500 4.3500 16,120,800
Jan 01, 2022 12.6200 13.7000 5.3100 6.0800 6.0800 25,090,900
Dec 01, 2021 13.0300 14.6900 10.7100 12.6200 12.6200 29,715,500
Oct 31, 2021 13.1500 18.6800 11.5400 13.0100 13.0100 58,732,900
Sep 30, 2021 91.5000 98.5000 12.4100 13.2000 13.2000 55,719,500
Aug 31, 2021 96.0400 101.7600 81.7000 91.6600 91.6600 4,687,000
Jul 31, 2021 57.1100 121.9800 55.3000 96.3000 96.3000 8,573,500


BRIEF-Quince Therapeutics Provides Pipeline Update And Business Outlook For 2023

Jan 30 (Reuters) - Quince Therapeutics Inc :
* QUINCE THERAPEUTICS PROVIDES PIPELINE UPDATE AND BUSINESS
OUTLOOK FOR 2023
* QUINCE THERAPEUTICS PROVIDES PIPELINE UPDATE AND BUSINESS
OUTLOOK FOR 2023
* QUINCE THERAPEUTICS - STRONG CASH POSITION OF
APPROXIMATELY $94
MILLION IN CASH, EQUIVALENTS, AND MARKETABLE SECURITIES AS OF
DECEMBER 31, 2022 and Potential for Quince to receive up to $150 million in regulatory and commercial milestones payments on a product-by-product basis, subject to conditions in the agreement
https://finance.yahoo.com/news/quince-therapeutics-completes-sale-legacy-130000851.html
* QUINCE THERAPEUTICS - CASH RUNWAY TO SUPPORT PIPELINE
EXPANSION
THROUGH IN-LICENSING AND ACQUISITION INTO AT LEAST 2028

Total Cash (mrq) 94.34M
Total Cash Per Share (mrq) 2.61
Total Debt (mrq) 420k
Shares Outstanding 36.13M
Float 27.6M